Latest Lead News

Mad Paws shareholders have overwhelmingly approved the acquisition by Rover Group, setting the stage for a significant shift in Australia's leading pet services marketplace.

Sunrise Energy Metals has nearly doubled its scandium resource at the Syerston Project and attracted significant US government financing interest, underscoring the strategic value of its critical minerals assets amid tightening global supply.

Supply Network Limited reported robust FY2025 results with double-digit revenue growth, expanded capacity across Australia and New Zealand, and announced a new auditor appointment at its AGM.

NSX Limited has been fully acquired by a Canadian entity, leading to the suspension and imminent delisting of its shares from the ASX. A new non-executive director has been nominated as part of the transition.

Smartpay Holdings has secured final court approval for its acquisition by Shift4 Holdings, setting the stage for share suspension and delisting in early November. Shareholders will receive NZ$1.20 per share in cash upon completion, pending final conditions.

Jindalee Lithium has raised approximately A$8 million through a share placement priced at 55 cents per share, while also issuing options to key participants. Further share and option issuances await shareholder approval in December.

Mad Paws Holdings Limited convened a pivotal Scheme Meeting to seek shareholder approval for its $61.5 million acquisition by Rover Group, Inc., with the Board unanimously backing the deal. Key conditions precedent have been met, setting the stage for final court approval and scheme implementation in November.

Caprice Resources has appointed CEO Luke Cox as Managing Director, underscoring confidence in his leadership to drive exploration and development in the Murchison Goldfields and West Arunta regions.

Cuscal Limited has secured a crucial regulatory win as the ACCC clears its full acquisition of Indue Limited, setting the stage for completion by year-end pending final approvals.

EVT Limited reports a robust 20.7% rise in Q1 EBITDA, driven by all divisions, with Hotels leading record results and a strategic acquisition poised to boost earnings further.

Memphasys secures a follow-up order for its Felix™ sperm selection cartridges from a leading Japanese fertility clinic, marking growing adoption in one of the world’s largest IVF markets and signaling a strategic shift to direct sales.

Corporate Travel Management reports a 6% revenue increase and a 29% rise in EBITDA for 1QFY26, maintaining operational strength amid an ongoing audit review and trading suspension.